Molecular biophysics of membranes

January 22, 2016

Bethesda, MD - This SRC will focus on biophysical and structural principles explaining molecular mechanisms in membranes and underlying membrane structure and function. Membranes form the defining boundaries of cells and their organelles. Many metabolic and regulatory functions of cells are carried out by membrane proteins including receptors, transporters, ion channels, proteins involved in signal transduction and energy conversion and many more. All these proteins function in the context of lipid bilayers that can bend, segregate components to form specialized protein and lipid clusters, change their shapes, fuse and separate in processes that require highly specialized molecular machines.

The basis of membrane protein structure, dynamic transformation and molecular regulation in the context of large and small membrane systems will be discussed. A principal objective is to stimulate cross-pollination of ideas amongst a diverse group of cell biologists, biochemists, physiologists and biophysicists by bringing them together in an intimate setting to share the latest developments in their fields. Program topics include protein and carbohydrate synthesis in the membrane, membrane signaling, G-protein coupled receptors, intracellular vesicle traffic, exo- and endocytosis, virus entry, mechanisms of ion channels and membrane transporters, clustering and shaping of membrane components in immune recognition, and folding of membrane proteins and amyloids. Biologists will learn about cutting edge biophysical techniques of membrane biology and biophysicists will learn about the latest developments in diverse biological fields of membrane systems, including many that are related to human diseases such as membrane signaling in cancer, membrane transport in cardiovascular disease and diabetes, synaptic transmission and amyloid deposition in neurological and neurodegenerative diseases, and entry pathways, antibiotic resistance, and immune response in infectious diseases.

A significant number of submitted abstracts will be selected for short talks. A specific "meet the experts" session and social activities will allow students and postdoctoral researchers to mingle with invited speakers including two Nobel laureates, to exchange ideas, and to formulate new collaborations.

FASEB has announced a total of 36 Science Research Conferences (SRC) in 2016. Registration opens Jan. 7, 2016. For more information about an SRC, view preliminary programs, or find a listing of all our 2016 SRCs, please visit http://www.faseb.org/SRC.
-end-
Since 1982, FASEB SRC has offered a continuing series of inter-disciplinary exchanges that are recognized as a valuable complement to the highly successful society meetings. Divided into small groups, scientists from around the world meet intimately and without distractions to explore new approaches to those research areas undergoing rapid scientific changes. In efforts to expand the SRC series, potential organizers are encouraged to contact SRC staff at SRC@faseb.org. Proposal guidelines can be found at http://www.faseb.org/SRC.

FASEB is composed of 30 societies with more than 125,000 members, making it the largest coalition of biomedical research associations in the United States. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.

Federation of American Societies for Experimental Biology

Related Cardiovascular Disease Articles from Brightsurf:

Changes by income level in cardiovascular disease in US
Researchers examined changes in how common cardiovascular disease was in the highest-income earners compared with the rest of the population in the United States between 1999 and 2016.

Fighting cardiovascular disease with acne drug
Researchers from the European Molecular Biology Laboratory (EMBL) in Heidelberg and Stanford University have found the cause of dilated cardiomyopathy - a leading cause of heart failure - and identified a potential treatment for it: a drug already used to treat acne.

A talk with your GP may prevent cardiovascular disease
Having a general practitioner (GP) who is trained in motivational interviewing may reduce your risk of getting cardiovascular disease.

Dilemma of COVID-19, aging and cardiovascular disease
Whether individuals should continue to take angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the context of coronavirus disease 2019 (COVID-19) is discussed in this article.

Air pollution linked to dementia and cardiovascular disease
People continuously exposed to air pollution are at increased risk of dementia, especially if they also suffer from cardiovascular diseases, according to a study at Karolinska Institutet in Sweden published in the journal JAMA Neurology.

New insights into the effect of aging on cardiovascular disease
Aging adults are more likely to have - and die from - cardiovascular disease than their younger counterparts.

Premature death from cardiovascular disease
National data were used to examine changes from 2000 to 2015 in premature death (ages 25 to 64) from cardiovascular disease in the United States.

Ultrasound: The potential power for cardiovascular disease therapy
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 2, pp.

Despite the ACA, millions of Americans with cardiovascular disease still can't get care
Cardiovascular disease (CVD) is the leading cause of death for Americans, yet millions with CVD or cardiovascular risk factors (CVRF) still can't access the care they need, even years after the implementation of the Affordable Care Act (ACA).

Excess weight and body fat cause cardiovascular disease
In the first Mendelian randomization study to look at this, researchers have found evidence that excess weight and body fat cause a range of heart and blood vessel diseases (rather than just being associated with it).

Read More: Cardiovascular Disease News and Cardiovascular Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.